By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • Health Topics
    • Diabetes
    • Cancer
    • Cardiovascular
    • Mental Health
    • Vaccines
    • Supplements
    • Migration & Health
    • Patient Safety & Accreditation
    • Occupational Safety and Health
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • Health Topics
    • Diabetes
    • Cancer
    • Cardiovascular
    • Mental Health
    • Vaccines
    • Supplements
    • Migration & Health
    • Patient Safety & Accreditation
    • Occupational Safety and Health
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > GMJ Briefs > Key Finding: Rb Pathway Inactivation Drives Squamous Transformation in EGFR-Mutant Lung Cancers

Key Finding: Rb Pathway Inactivation Drives Squamous Transformation in EGFR-Mutant Lung Cancers

GMJ
Last updated: 26/07/2026 02:52
By
Prof. Giorgi Pkhakadze
Share
0 Min Read
Molecular diagram showing Rb pathway inactivation mechanism in EGFR-mutant lung tumor transformation
A clinicogenomic analysis published in Science Translational Medicine reveals that retinoblastoma pathway inactivation drives squamous transformation in EGFR-mutant lung adenocarcinomas, offering new targets for intervention and early detection strategies. — Photo by Egor Komarov on Pexels (Pexels License)
SHARE
1 min read|41 words

Rb pathway inactivation emerges as the consistent molecular feature driving squamous transformation in EGFR-mutant lung cancers—a finding that could enable earlier intervention and prevent treatment resistance. New research in Science Translational Medicine (June 2026).

Read the full article on GMJ Newsroom →

Was this article helpful?

GMJ Brief · Key Finding

📰 Read the full article: Rb Pathway Inactivation Drives Squamous Transformation in EGFR-Mutant Lung Cancers →

Related reference
  • Lung Cancer · Condition
Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
UK Approves COVID-19 Test Products: What Healthcare Providers Need to Know

The UK Department of Health and Social Care has published an authoritative…

UK’s MHRA Publishes Performance Data: Drug Approvals, Review Times, and Regulatory Efficiency Metrics

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) has published comprehensive…

Teaching Children to Make Safe Choices: Beyond Protective Barriers

Approximately 20 US children die daily from unintentional injuries. While car seats…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

EBOLA OUTBREAK CLUSTER ALERT – DRC/UGANDA CROSS-BORDER TRANSMISSION

By
Prof. Giorgi Pkhakadze
31/05/2026
Cancer patient exercising at home during chemotherapy treatment for cognitive protection

New Data Reveals Scope of Chemo Brain and Promise of Exercise Intervention

By
Prof. Giorgi Pkhakadze
09/07/2026
Illustration of amino acid supplement bottles with warning symbol and life expectancy graph overlay

Study Quantifies Mortality Signal: One Year of Life Expectancy Lost with High Tyrosine Levels

By
Prof. Giorgi Pkhakadze
25/07/2026
Global HealthPolicy & Systems

WHO Declares Emergency as Ebola Outbreak Spreads from DR Congo to Uganda

By
Prof. Giorgi Pkhakadze
31/05/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up